Congestive Heart Failure - The Left Main and Coronary Artery Bifurcation Lesion Summit (CBS)

Abstract

sST2 Predicts Outcome in Chronic Heart Failure Beyond NT−proBNP and High-Sensitivity Troponin T
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
Lifestyle Modifications for Preventing and Treating Heart Failure
Association Between Functional Impairment and Medication Burden in Adults with Heart Failure
The Future of Biomarker-Guided Therapy for Heart Failure After the Guiding Evidence-Based Therapy Using Biomarker Intensified Treatment in Heart Failure (GUIDE-IT) Study
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
Baseline Features of the VICTORIA (Vericiguat Global Study in Subjects With Heart Failure With Reduced Ejection Fraction) Trial
Heart Failure With Improved Ejection Fraction-Is it Possible to Escape One’s Past?
Cardiac Resynchronization Therapy in Inotrope-Dependent Heart Failure Patients - A Systematic Review and Meta-Analysis

Consensus

Volume 74, Issue 15, October 2019

JOURNAL：J Am Coll Cardiol.

2019 ACC Expert Consensus Decision Pathway on Risk Assessment, Management, and Clinical Trajectory of Patients Hospitalized With Heart Failure A Report of the American College of Cardiology Solution Set Oversight Committee

SM Hollenberg, LW Stevenson, T Ahmad et al.

3059

Keywords: decision pathway; angiotensin receptor-neprilysin inhibitors; beta blockers; CHFcomorbidities; diuretics; guideline-directed medical therapy; heart failure

FULL TEXT PDF